A Double-Blind, Placebo-Controlled Study for Effects of Daily Oral Administration of "Dattan Soba Seikatsu" on Blood pressure and Blood flow improvement.
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000026254
- Lead Sponsor
- Hokkaido Information University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 46
Not provided
1. Subjects who are under treatment and medication for diabetes and dyslipidemia. 2. Subjects with serious disease and infection. 3. Subjects with clinical history of gastrointestinal surgery. 4. Subjects with unusually high and/or low blood pressure, or with abnormal hematological data. 5. Subjects with serious anemia. 6. Subjects with frequent complaints of post-menopausal symptoms. 7. Subjects with a history of allergy to medicine and food, especially buckwheat and/or gelatin. 8. Subjects regularly take medicine, functional foods and/or supplements which would affect blood pressure and blood flow. 9. Subjects can not stop an intake of medicine, functional foods, supplements, buckwheat and Tartary buckwheat. 10. Subjects who are heavy smokers and alcohol addicts, or subjects with irregular lifestyle. 11. Subjects who donated either 400 ml whole blood within 12 weeks (men) /16 weeks (women) or 200 ml whole blood within 4 weeks or blood components within 2 weeks prior to this study. 12. Subjects who are pregnant or under lactation, or ones who would be expected to be pregnant during the study. 13. Subjects who participate in other clinical trials within the last 4 weeks prior to the current clinical trial. 14. Subjects who are not eligible due to physician's judgment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method